| Ticker Details |
|
Standard BioTools Inc.
|
| IPO Date: |
March 1, 2011 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$402.08M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.06 | 3.48%
|
| Avg Daily Range (30 D): |
$0.03 | 2.70%
|
| Avg Daily Range (90 D): |
$0.03 | 2.51%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.34M |
| Avg Daily Volume (30 D): |
2.49M |
| Avg Daily Volume (90 D): |
1.92M |
| Trade Size |
| Avg Trade Size (Sh.): |
200 |
| Avg Trade Size (Sh.) (30 D): |
245 |
| Avg Trade Size (Sh.) (90 D): |
237 |
| Institutional Trades |
| Total Institutional Trades: |
133 |
| Avg Institutional Trade: |
$1.8M |
| Avg Institutional Trade (30 D): |
$.69M |
| Avg Institutional Trade (90 D): |
$1.01M |
| Avg Institutional Trade Volume: |
.99M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.74M |
| Avg Closing Trade (30 D): |
$.69M |
| Avg Closing Trade (90 D): |
$.9M |
| Avg Closing Volume: |
1.5M |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$.33
|
$.05
|
$-.2
|
|
Diluted EPS
|
$.33
|
$.05
|
$-.2
|
|
Revenue
|
$21.15M
|
$23.8M
|
$85.33M
|
|
Gross Profit
|
$11.31M
|
$11.38M
|
$42.54M
|
|
Net Income / Loss
|
$127.07M
|
$19.28M
|
$-74.9M
|
|
Operating Income / Loss
|
$-12.5M
|
$-24.64M
|
$-110.25M
|
|
Cost of Revenue
|
$9.84M
|
$12.41M
|
$42.79M
|
|
Net Cash Flow
|
$144.57M
|
$-8.71M
|
$-45.52M
|
|
PE Ratio
|
|
|
|
|
|
|